DE69728380D1 - Streptokokken c5a peptidase impfstoff - Google Patents
Streptokokken c5a peptidase impfstoffInfo
- Publication number
- DE69728380D1 DE69728380D1 DE69728380T DE69728380T DE69728380D1 DE 69728380 D1 DE69728380 D1 DE 69728380D1 DE 69728380 T DE69728380 T DE 69728380T DE 69728380 T DE69728380 T DE 69728380T DE 69728380 D1 DE69728380 D1 DE 69728380D1
- Authority
- DE
- Germany
- Prior art keywords
- streptococcle
- peptidase
- vaccine
- infection
- disclosed
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 229960005486 vaccine Drugs 0.000 title abstract 4
- 108010059574 C5a peptidase Proteins 0.000 title abstract 2
- 241000194017 Streptococcus Species 0.000 abstract 2
- 208000015181 infectious disease Diseases 0.000 abstract 2
- 241000124008 Mammalia Species 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
- A61K39/092—Streptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/2111—C5a peptidase (3.4.21.110)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US589756 | 1996-01-22 | ||
US08/589,756 US5846547A (en) | 1996-01-22 | 1996-01-22 | Streptococcal C5a peptidase vaccine |
PCT/US1997/001056 WO1997026008A1 (en) | 1996-01-22 | 1997-01-21 | STREPTOCOCCAL C5a PEPTIDASE VACCINE |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69728380D1 true DE69728380D1 (de) | 2004-05-06 |
DE69728380T2 DE69728380T2 (de) | 2005-01-27 |
Family
ID=24359391
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69728380T Expired - Lifetime DE69728380T2 (de) | 1996-01-22 | 1997-01-21 | Streptokokken C5A Peptidase Impfstoff |
Country Status (12)
Country | Link |
---|---|
US (2) | US5846547A (de) |
EP (1) | EP0877624B1 (de) |
JP (1) | JP4361606B2 (de) |
KR (1) | KR100582138B1 (de) |
AT (1) | ATE262924T1 (de) |
AU (1) | AU705732B2 (de) |
CA (1) | CA2243755C (de) |
DE (1) | DE69728380T2 (de) |
DK (1) | DK0877624T3 (de) |
ES (1) | ES2218656T3 (de) |
PT (1) | PT877624E (de) |
WO (1) | WO1997026008A1 (de) |
Families Citing this family (49)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5846547A (en) * | 1996-01-22 | 1998-12-08 | Regents Of The University Of Minnesota | Streptococcal C5a peptidase vaccine |
US6355255B1 (en) * | 1998-12-07 | 2002-03-12 | Regents Of The University Of Minnesota | Streptococcal C5a peptidase vaccine |
US6676943B1 (en) | 1997-04-24 | 2004-01-13 | Regents Of The University Of Minnesota | Human complement C3-degrading protein from Streptococcus pneumoniae |
AU755343B2 (en) * | 1997-12-31 | 2002-12-12 | Montana State University-Bozeman | A method of isolating a peptide which immunologically mimics microbial carbohydrates including group B streptococcal carbohydrates and the use thereof in a vaccine |
IL142017A0 (en) * | 1998-09-24 | 2002-03-10 | Univ Minnesota | Human complement c3-degrading polypeptide from streptococcus pneumoniae |
US7256265B2 (en) * | 1999-12-03 | 2007-08-14 | Regents Of The University Of Minnesota | Streptococcal C5a peptidase vaccine |
AU2004226909B2 (en) * | 2000-10-27 | 2008-02-07 | J. Craig Venter Institute, Inc. | Nucleic acids and proteins from streptococcus groups A & B |
MXPA03003690A (es) * | 2000-10-27 | 2004-05-05 | Chiron Spa | Acidos nucleicos y proteinas de los grupos a y b de estreptococos. |
GB2370770B (en) * | 2001-01-03 | 2005-06-01 | Simon Connolly | Uses of Streptococcus Vaccines |
MX339524B (es) | 2001-10-11 | 2016-05-30 | Wyeth Corp | Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica. |
AU2003260102A1 (en) * | 2002-08-26 | 2004-03-11 | Chiron Corporation | Conserved and specific streptococcal genomes |
US7785608B2 (en) * | 2002-08-30 | 2010-08-31 | Wyeth Holdings Corporation | Immunogenic compositions for the prevention and treatment of meningococcal disease |
US7301554B2 (en) * | 2002-09-20 | 2007-11-27 | Ricoh Company, Ltd. | Light scanning device, scanning line adjusting method, scanning line adjusting control method, image forming apparatus, and image forming method |
EP1648500B1 (de) | 2003-07-31 | 2014-07-09 | Novartis Vaccines and Diagnostics, Inc. | Immunogene zusammensetzungen für streptococcus pyogenes |
US8945589B2 (en) * | 2003-09-15 | 2015-02-03 | Novartis Vaccines And Diagnostics, Srl | Immunogenic compositions for Streptococcus agalactiae |
EP2612679A1 (de) * | 2004-07-29 | 2013-07-10 | Novartis Vaccines and Diagnostics, Inc. | Immunogene Zusammensetzungen für grampositive Bakterien wie etwa Streptococcus agalactiae |
JP2008544949A (ja) * | 2004-10-08 | 2008-12-11 | ノバルティス バクシンズ アンド ダイアグノスティックス,インコーポレーテッド | 化膿性レンサ球菌のための免疫激性組成物および治療用組成物 |
TW200806315A (en) | 2006-04-26 | 2008-02-01 | Wyeth Corp | Novel formulations which stabilize and inhibit precipitation of immunogenic compositions |
US20110206692A1 (en) * | 2006-06-09 | 2011-08-25 | Novartis Ag | Conformers of bacterial adhesins |
US7364291B2 (en) * | 2006-06-29 | 2008-04-29 | Johnson & Johnson Vision Care, Inc. | Contact lenses with light blocking rings |
WO2008108830A2 (en) * | 2006-10-30 | 2008-09-12 | Novartis Ag | Immunogenic and therapeutic compositions for streptococcus pyogenes |
US20080311129A1 (en) * | 2006-11-02 | 2008-12-18 | Camas Incorporated | Adherence inhibitor directed to and method of making and using |
AR064642A1 (es) | 2006-12-22 | 2009-04-15 | Wyeth Corp | Polinucleotido vector que lo comprende celula recombinante que comprende el vector polipeptido , anticuerpo , composicion que comprende el polinucleotido , vector , celula recombinante polipeptido o anticuerpo , uso de la composicion y metodo para preparar la composicion misma y preparar una composi |
HU227970B1 (en) | 2007-07-10 | 2012-07-30 | Egis Gyogyszergyar Nyrt | Pharmaceutical compositions containing silicones of high volatility |
KR101621837B1 (ko) | 2007-09-12 | 2016-05-17 | 노파르티스 아게 | Gas57 돌연변이 항원 및 gas57 항체 |
CN104292312A (zh) | 2007-12-21 | 2015-01-21 | 诺华股份有限公司 | 链球菌溶血素o的突变形式 |
AU2009313615B2 (en) | 2008-11-05 | 2012-11-29 | Regents Of The University Of Minnesota | Multicomponent immunogenic composition for the prevention of beta-hemolytic streptococcal (BHS) disease |
PL3170508T3 (pl) | 2010-06-04 | 2020-04-30 | Wyeth Llc | Preparaty szczepionek |
ES2850973T3 (es) | 2010-08-23 | 2021-09-01 | Wyeth Llc | Formulaciones estables de antígenos rLP2086 de Neisseria meningitidis |
WO2012032489A1 (en) | 2010-09-10 | 2012-03-15 | Wyeth Llc | Non-lipidated variants of neisseria meningitidis orf2086 antigens |
ITMI20111182A1 (it) | 2011-06-28 | 2012-12-29 | Canio Buonavoglia | Vaccino per coronavirus canino |
US9078842B2 (en) | 2011-10-26 | 2015-07-14 | Wisconsin Alumni Research Foundation | Peptide for reducing the phosphate requirement and excretion from farm animals |
NZ628449A (en) | 2012-03-09 | 2016-04-29 | Pfizer | Neisseria meningitidis compositions and methods thereof |
SA115360586B1 (ar) | 2012-03-09 | 2017-04-12 | فايزر انك | تركيبات لعلاج الالتهاب السحائي البكتيري وطرق لتحضيرها |
JP6446377B2 (ja) | 2013-03-08 | 2018-12-26 | ファイザー・インク | 免疫原性融合ポリペプチド |
CA2923129C (en) | 2013-09-08 | 2020-06-09 | Pfizer Inc. | Neisseria meningitidis compositions and methods thereof |
EP2886140A1 (de) * | 2013-12-17 | 2015-06-24 | University of Limerick | Vorrichtung zur extrakorporalen Behandlung von Blut |
US9815886B2 (en) | 2014-10-28 | 2017-11-14 | Adma Biologics, Inc. | Compositions and methods for the treatment of immunodeficiency |
BR112017017460A2 (pt) | 2015-02-19 | 2018-04-10 | Pfizer Inc. | composições de neisseria meningitidis e métodos das mesmas |
US10544197B2 (en) * | 2016-08-12 | 2020-01-28 | Wisconsin Alumni Research Foundation | FGF-23 epitope peptide for improving resistance to breakage and eggshell strength |
CN110234658B (zh) | 2017-01-31 | 2024-03-12 | 辉瑞大药厂 | 脑膜炎奈瑟菌组合物及其使用方法 |
US10259865B2 (en) | 2017-03-15 | 2019-04-16 | Adma Biologics, Inc. | Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection |
MX2023004912A (es) | 2020-10-27 | 2023-05-16 | Pfizer | Composiciones de escherichia coli y metodos de las mismas. |
US20220202923A1 (en) | 2020-12-23 | 2022-06-30 | Pfizer Inc. | E. coli fimh mutants and uses thereof |
TW202306969A (zh) | 2021-05-28 | 2023-02-16 | 美商輝瑞大藥廠 | 包含結合之莢膜醣抗原的免疫原組合物及其用途 |
BR112023023671A2 (pt) | 2021-05-28 | 2024-02-06 | Pfizer | Composições imunogênicas compreendendo antígenos de sacarídeo capsular conjugados e usos dos mesmos |
WO2023135515A1 (en) | 2022-01-13 | 2023-07-20 | Pfizer Inc. | Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof |
WO2024110827A1 (en) | 2022-11-21 | 2024-05-30 | Pfizer Inc. | Methods for preparing conjugated capsular saccharide antigens and uses thereof |
WO2024110839A2 (en) | 2022-11-22 | 2024-05-30 | Pfizer Inc. | Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4454121A (en) * | 1982-07-27 | 1984-06-12 | The University Of Tennessee Research Corporation | Synthetic peptides corresponding to antigenic determinants of the M protein of Streptococcus pyogenes |
US4695562A (en) * | 1984-04-06 | 1987-09-22 | Univ. Of Tennessee Research Corp. | Synthetic peptide compounds |
US4772584A (en) * | 1986-05-23 | 1988-09-20 | Cleary Paul P | Inhibitor of C5a-mediated chemotaxis |
US5124153A (en) * | 1987-08-24 | 1992-06-23 | University Of Tennessee Research Corp. | Therapeutic compositions against streptococcal infections, transformed hosts, methods of immunization and genetically engineered products |
US5162226A (en) * | 1987-08-24 | 1992-11-10 | University Of Tennessee Research Corp. (U.T.R.C.) | Therapeutic compositions against streptococcal infections, transformed hosts, methods of immunization and genetically engineered products |
AU630093B2 (en) * | 1988-03-25 | 1992-10-22 | Rockefeller University, The | Synthetic peptides from streptococcal m protein and vaccines prepared therefrom |
CA2127550A1 (en) * | 1992-01-08 | 1993-07-22 | Vincent Fischetti | Multifunctional surface protein of streptococci |
WO1993021220A1 (en) * | 1992-04-08 | 1993-10-28 | The Council Of The Queensland Institute Of Medical Research | Synthetic peptides useful in a vaccine against and in the diagnosis of streptococcal infection |
DE69331437T2 (de) * | 1992-09-16 | 2002-09-05 | Univ Tennessee Res Corp | Antigene des hybriden m-proteins und träger für gruppe a streptokokkenimpfstoff |
ES2170075T3 (es) * | 1992-09-16 | 2002-08-01 | Univ Tennessee Res Corp | Vacuna de proteina m recombinante multivalente. |
US5866135A (en) * | 1994-04-21 | 1999-02-02 | North American Vaccine, Inc. | Group A streptococcal polysaccharide immunogenic compositions and methods |
US5846547A (en) | 1996-01-22 | 1998-12-08 | Regents Of The University Of Minnesota | Streptococcal C5a peptidase vaccine |
-
1996
- 1996-01-22 US US08/589,756 patent/US5846547A/en not_active Expired - Lifetime
-
1997
- 1997-01-21 WO PCT/US1997/001056 patent/WO1997026008A1/en not_active Application Discontinuation
- 1997-01-21 ES ES97902076T patent/ES2218656T3/es not_active Expired - Lifetime
- 1997-01-21 AU AU15828/97A patent/AU705732B2/en not_active Expired
- 1997-01-21 CA CA002243755A patent/CA2243755C/en not_active Expired - Lifetime
- 1997-01-21 KR KR1019980705574A patent/KR100582138B1/ko not_active IP Right Cessation
- 1997-01-21 DE DE69728380T patent/DE69728380T2/de not_active Expired - Lifetime
- 1997-01-21 DK DK97902076T patent/DK0877624T3/da active
- 1997-01-21 AT AT97902076T patent/ATE262924T1/de active
- 1997-01-21 PT PT97902076T patent/PT877624E/pt unknown
- 1997-01-21 EP EP97902076A patent/EP0877624B1/de not_active Expired - Lifetime
- 1997-01-21 JP JP52630197A patent/JP4361606B2/ja not_active Expired - Lifetime
-
1998
- 1998-12-07 US US09/206,800 patent/US6270775B1/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
CA2243755C (en) | 2006-10-31 |
EP0877624A1 (de) | 1998-11-18 |
KR100582138B1 (ko) | 2006-08-30 |
PT877624E (pt) | 2004-08-31 |
EP0877624B1 (de) | 2004-03-31 |
WO1997026008A1 (en) | 1997-07-24 |
CA2243755A1 (en) | 1997-07-24 |
AU705732B2 (en) | 1999-05-27 |
AU1582897A (en) | 1997-08-11 |
DK0877624T3 (da) | 2004-06-21 |
KR19990081863A (ko) | 1999-11-15 |
JP2000513709A (ja) | 2000-10-17 |
JP4361606B2 (ja) | 2009-11-11 |
DE69728380T2 (de) | 2005-01-27 |
ES2218656T3 (es) | 2004-11-16 |
US5846547A (en) | 1998-12-08 |
ATE262924T1 (de) | 2004-04-15 |
US6270775B1 (en) | 2001-08-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69728380D1 (de) | Streptokokken c5a peptidase impfstoff | |
EP1137785B8 (de) | STREPTOKOKKEN-C5a-PEPTIDASE-IMPFSTOFF | |
ATE242319T1 (de) | Deletionsmutanten als impfstoffe gegen cholera | |
DK0550477T3 (da) | Inaktiveret Mycoplasma hyopneumoniae-bakterin og fremgangsmåde til anvendelse deraf | |
CY2570B1 (en) | Compounds for immunotherapy and diagnosis of tuberculosis | |
FI952445A (fi) | Pneumokokiantigeenien annostelu limakalvojen kautta | |
DK0651609T3 (da) | Pasteurella multocida toxoidvacciner | |
DE69824794D1 (de) | Streptococcus equi Impfstoff | |
MX9604262A (es) | Antigenos de pasteurellaceae y vacunas relacionadas. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |